Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MESA LABORATORIES INC /CO/MLAB · Entity 5221 | SVP Operations | June 18, 2026 | June 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MESA LABORATORIES INC /CO/
Report date June 18, 2026 · Filed June 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,377 |
Ending reported balance
After 2026-06-22 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-06-18 · Exercise / conversion · Acquired 844 · Balance 4,554 Row 2 · 2026-06-18 · Exercise / conversion · Acquired 2,480 · Balance 7,034 Row 3 · 2026-06-18 · Grant · Acquired 1,859 · Balance 8,893 F5: Shares represent common stock of Mesa Labs issued upon release of performance share units issued under the FY24-FY26 performance share unit program Row 4 · 2026-06-22 · Sale · Disposed 2,516 · Balance 6,377 |
| Restricted Stock Units - 7SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-06-18 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-06-18 · Exercise / conversion · Disposed 844 · Balance 0 F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2: RSUs that vested June 21, 2024 and each of the next two anniversary dates F3: Not Applicable |
| Restricted Stock Units - 8SEC Table II · derivative / convertible security · Expires 2025-06-18 | Direct | 2,480 |
Reported balance
After 2026-06-18 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-06-18 · Exercise / conversion · Disposed 2,480 · Balance 2,480 F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock F3: Not Applicable F4: RSUs that vest 1/3 on June 15, 2026 and each of the next 2 anniversary dates |
Filing footnotes · ownership attribution and instrument terms
F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock
F2: RSUs that vested June 21, 2024 and each of the next two anniversary dates
F3: Not Applicable
F4: RSUs that vest 1/3 on June 15, 2026 and each of the next 2 anniversary dates
F5: Shares represent common stock of Mesa Labs issued upon release of performance share units issued under the FY24-FY26 performance share unit program
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2022 Filed Sep 2, 2022 17:14 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Unit - 5 · Derivative | 546 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000039 · primary_doc.xml · derivative · entry 4 Archbold Brian David · CIK 0001776947 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 546 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest on September 1, 2022 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 17:14 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Tax withholdingCommon Stock | 412 | $178.42 | $73,509.04 |
DisclosureSEC source: 0001228924-22-000039 · primary_doc.xml · nonDerivative · entry 3 Archbold Brian David · CIK 0001776947 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,304 Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 17:14 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 357 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000039 · primary_doc.xml · nonDerivative · entry 2 Archbold Brian David · CIK 0001776947 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,716 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 17:14 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 546 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000039 · primary_doc.xml · nonDerivative · entry 1 Archbold Brian David · CIK 0001776947 · VP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,359 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 21, 2022 Filed Jun 22, 2022 18:25 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 392 | $188.22 | $73,783.81 |
DisclosureSEC source: 0001228924-22-000020 · primary_doc.xml · nonDerivative · entry 4 Archbold Brian David · CIK 0001776947 · SVP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 813 F7 · shares: Shares sold to cover taxes associated with Performance Share Units Read SEC document |
| June 21, 2022 Filed Jun 22, 2022 18:25 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantCommon Stock | 868 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000020 · primary_doc.xml · nonDerivative · entry 3 Archbold Brian David · CIK 0001776947 · SVP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,205 F6 · shares: Shares represent common stock of Mesa Labs issued upon release of performance share units issued under the FY20-FY22 performance share unit program Read SEC document |
| June 17, 2022 Filed Jun 22, 2022 18:25 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 2 · Derivative | 268 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000020 · primary_doc.xml · derivative · entry 6 Archbold Brian David · CIK 0001776947 · SVP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267 Underlying: Common Stock · 268 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents the contingent right to receive one share of the Issuer's common stock F4 · derivative.exercise_date: RSUs that vest 1/3 on June 15, 2021 and each of the next two anniversary dates F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 17, 2022 Filed Jun 22, 2022 18:25 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 1 · Derivative | 70 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000020 · primary_doc.xml · derivative · entry 5 Archbold Brian David · CIK 0001776947 · SVP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70 Underlying: Common Stock · 70 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents the contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest 1/5 on June 15, 2019 and each of the next four anniversary dates F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 17, 2022 Filed Jun 22, 2022 18:25 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Tax withholdingCommon Stock | 155 | $185.57 | $28,763.35 |
DisclosureSEC source: 0001228924-22-000020 · primary_doc.xml · nonDerivative · entry 2 Archbold Brian David · CIK 0001776947 · SVP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 337 F5 · shares: Represents shares of common stock receive by Mesa Labs for tax withholding purposes in connection with the net-settlement of the issuance of shares of common stock in respect to the vested RSUs Read SEC document |
| June 17, 2022 Filed Jun 22, 2022 18:25 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 338 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000020 · primary_doc.xml · nonDerivative · entry 1 Archbold Brian David · CIK 0001776947 · SVP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 492 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 17:12 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantNon Qualified Stock Option · Derivative | 3,852 | $0.00 Strike: $185.57 | $0.00 |
DisclosureSEC source: 0001228924-22-000014 · primary_doc.xml · derivative · entry 2 Archbold Brian David · CIK 0001776947 · SVP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,827 Underlying: Common Stock · 3,852 shares Expires 2028-06-15 F4 · derivative.exercise_date: NSOs that vest 1/3 June 15, 2023, 1/3 on June 15, 2024 and 1/3 on June 15, 2025 Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 17:12 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 6 · Derivative | 1,604 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000014 · primary_doc.xml · derivative · entry 1 Archbold Brian David · CIK 0001776947 · SVP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,604 Underlying: Common Stock · 1,604 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest 1/3 on June 15, 2023, 1/3 on June 15, 2024 and 1/3 on June 15, 2025 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| December 14, 2021 Filed Dec 15, 2021 15:53 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 917 | $0.00 Strike: $226.72 | $0.00 |
DisclosureSEC source: 0001228924-21-000083 · primary_doc.xml · derivative · entry 7 Archbold Brian David · CIK 0001776947 · SVP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,975 Underlying: Common Stock · 917 shares Expires 2026-06-15 F3 · derivative.exercise_date: 1/3 exercisable on each anniversary date of the 06-15-2020 grant date Read SEC document |
| December 14, 2021 Filed Dec 15, 2021 15:53 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 532 | $0.00 Strike: $203.54 | $0.00 |
DisclosureSEC source: 0001228924-21-000083 · primary_doc.xml · derivative · entry 6 Archbold Brian David · CIK 0001776947 · SVP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,892 Underlying: Common Stock · 532 shares Expires 2025-06-10 F2 · derivative.exercise_date: 1/4 exercisable on each anniversary date of the 06-10-2019 grant date Read SEC document |
| December 14, 2021 Filed Dec 15, 2021 15:53 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 210 | $0.00 Strike: $142.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000083 · primary_doc.xml · derivative · entry 5 Archbold Brian David · CIK 0001776947 · SVP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,424 Underlying: Common Stock · 210 shares Expires 2024-04-02 F1 · derivative.exercise_date: 1/5 exercisable on each anniversary date of the 04-02-2018 grant date Read SEC document |
| December 14, 2021 Filed Dec 15, 2021 15:53 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 1,659 | $325.02 | $539,208.18 |
DisclosureSEC source: 0001228924-21-000083 · primary_doc.xml · nonDerivative · entry 4 Archbold Brian David · CIK 0001776947 · SVP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154 Read SEC document |
| December 14, 2021 Filed Dec 15, 2021 15:53 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 917 | $226.72 | $207,902.24 |
DisclosureSEC source: 0001228924-21-000083 · primary_doc.xml · nonDerivative · entry 3 Archbold Brian David · CIK 0001776947 · SVP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,813 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2021 Filed Dec 15, 2021 15:53 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 532 | $203.54 | $108,283.28 |
DisclosureSEC source: 0001228924-21-000083 · primary_doc.xml · nonDerivative · entry 2 Archbold Brian David · CIK 0001776947 · SVP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 896 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2021 Filed Dec 15, 2021 15:53 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 210 | $142.40 | $29,904.00 |
DisclosureSEC source: 0001228924-21-000083 · primary_doc.xml · nonDerivative · entry 1 Archbold Brian David · CIK 0001776947 · SVP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2021 Filed Sep 1, 2021 23:15 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantNon Qualified Stock Options · Derivative | 3,421 | $0.00 Strike: $268.85 | $0.00 |
DisclosureSEC source: 0001228924-21-000069 · primary_doc.xml · derivative · entry 3 Archbold Brian David · CIK 0001776947 · SVP Continuous Improvement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,634 Underlying: Common Stock · 3,421 shares Expires 2027-09-01 F6 · derivative.exercise_date: NSOs that vest 1/3 on September 1, 2022, 1/3 on June 15, 2023 and 1/3 on June 15, 2024 Read SEC document |
| September 01, 2021 Filed Sep 1, 2021 23:15 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 5 · Derivative | 546 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000069 · primary_doc.xml · derivative · entry 2 Archbold Brian David · CIK 0001776947 · SVP Continuous Improvement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 546 Underlying: Common Stock · 546 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive on share of the Issuer's common stock F4 · shares: RSUs granted for navigation of Company through Covid-19 F5 · derivative.exercise_date: RSUs that cliff vest on September 1, 2022 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| September 01, 2021 Filed Sep 1, 2021 23:15 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 4 · Derivative | 1,066 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000069 · primary_doc.xml · derivative · entry 1 Archbold Brian David · CIK 0001776947 · SVP Continuous Improvement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,066 Underlying: Common Stock · 1,066 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive on share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest 1/3 on September 1, 2022, 1/3 on June 15, 2023 and 1/3 on June 15, 2024 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| August 09, 2021 Filed Aug 12, 2021 16:05 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 639 | $280.03 | $178,939.17 |
DisclosureSEC source: 0001228924-21-000049 · primary_doc.xml · nonDerivative · entry 1 Archbold Brian David · CIK 0001776947 · SVP Continuous Improvement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154 Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 14:21 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 400 | $256.56 | $102,624.00 |
DisclosureSEC source: 0001228924-21-000043 · primary_doc.xml · nonDerivative · entry 1 Archbold Brian David · CIK 0001776947 · SVP Continuous Improvement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 793 Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 16:06 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 415 | $260.14 | $107,958.10 |
DisclosureSEC source: 0001228924-21-000038 · primary_doc.xml · nonDerivative · entry 3 Archbold Brian David · CIK 0001776947 · SVP Continuous Improvement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,193 Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 16:06 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 921 | $255.67 | $235,472.07 |
DisclosureSEC source: 0001228924-21-000038 · primary_doc.xml · nonDerivative · entry 2 Archbold Brian David · CIK 0001776947 · SVP Continuous Improvement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,608 F2 · shares: Shares sold to cover taxes associated with Performance Share Units Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 20:05 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Unit - 3 · Derivative | 419 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000033 · primary_doc.xml · derivative · entry 7 Archbold Brian David · CIK 0001776947 · VP of Continuous Improvement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 0 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock F5 · derivative.exercise_date: Restricted Stock Units granted for 10% salary reduction for the twelve months ended May 31, 2021 and 60% of cash bonus target for Fiscal Year 2021. F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 20:05 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Unit - 2 · Derivative | 277 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000033 · primary_doc.xml · derivative · entry 6 Archbold Brian David · CIK 0001776947 · VP of Continuous Improvement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 535 Underlying: Common Stock · 277 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock F4 · derivative.exercise_date: Restricted Stock Units that vest 1/3 on June 15, 2021 and each of the next two anniversary dates F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 20:05 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 1 · Derivative | 70 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000033 · primary_doc.xml · derivative · entry 5 Archbold Brian David · CIK 0001776947 · VP of Continuous Improvement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140 Underlying: Common Stock · 70 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: Restricted Stock Units that vest 1/5 on June 15, 2019 and each of the next four anniversary dates F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 20:05 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Tax withholdingCommon Stock | 351 | $263.30 | $92,418.30 |
DisclosureSEC source: 0001228924-21-000033 · primary_doc.xml · nonDerivative · entry 4 Archbold Brian David · CIK 0001776947 · VP of Continuous Improvement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 569 F6 · shares: Represents shares of common stock received by Mesa Labs for tax withholding purposes in connection with the net-settlement on the issuance of shares of common stock in respect to the vested RSUs. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 20:05 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 419 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000033 · primary_doc.xml · nonDerivative · entry 3 Archbold Brian David · CIK 0001776947 · VP of Continuous Improvement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 920 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 20:05 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 277 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000033 · primary_doc.xml · nonDerivative · entry 2 Archbold Brian David · CIK 0001776947 · VP of Continuous Improvement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 20:05 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 70 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000033 · primary_doc.xml · nonDerivative · entry 1 Archbold Brian David · CIK 0001776947 · VP of Continuous Improvement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 16:06 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantCommon Stock | 1,960 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000038 · primary_doc.xml · nonDerivative · entry 1 Archbold Brian David · CIK 0001776947 · SVP Continuous Improvement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,529 F1 · shares: Shares represent common stock of Mesa Labs issuable upon the release of performance share units issued under the FY2019-FY2021 performance share unit program. Read SEC document |
| March 11, 2021 Filed Mar 11, 2021 15:24 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 145 | $129.10 | $18,719.50 |
DisclosureSEC source: 0001228924-21-000010 · primary_doc.xml · nonDerivative · entry 1 Archbold Brian David · CIK 0001776947 · SVP Continuous Improvement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 377 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 15:24 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 145 | $0.00 Strike: $129.10 | $0.00 |
DisclosureSEC source: 0001228924-21-000010 · primary_doc.xml · derivative · entry 3 Archbold Brian David · CIK 0001776947 · SVP Continuous Improvement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,213 Underlying: Common Stock · 145 shares Expires 2024-01-08 F1 · derivative.exercise_date: 1/5 exercisable on each anniversary date of the 1/08/2018 grant Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 15:24 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 223 | $271.78 | $60,606.94 |
DisclosureSEC source: 0001228924-21-000010 · primary_doc.xml · nonDerivative · entry 2 Archbold Brian David · CIK 0001776947 · SVP Continuous Improvement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154 Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 21:18 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 533 | $0.00 Strike: $203.54 | $0.00 |
DisclosureSEC source: 0001228924-20-000030 · primary_doc.xml · derivative · entry 3 Archbold Brian David · CIK 0001776947 · SVP Continuous Improvement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,358 Underlying: Common Stock · 533 shares Expires 2025-06-10 F1 · derivative.exercise_date: 1/4 exercisable on each anniversary date Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 21:18 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 533 | $272.11 | $145,034.63 |
DisclosureSEC source: 0001228924-20-000030 · primary_doc.xml · nonDerivative · entry 2 Archbold Brian David · CIK 0001776947 · SVP Continuous Improvement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232 Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 21:18 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 533 | $203.54 | $108,486.82 |
DisclosureSEC source: 0001228924-20-000030 · primary_doc.xml · nonDerivative · entry 1 Archbold Brian David · CIK 0001776947 · SVP Continuous Improvement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2020 Filed Aug 13, 2020 20:31 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 420 | $0.00 Strike: $142.40 | $0.00 |
DisclosureSEC source: 0001437749-20-017829 · rdgdoc.xml · derivative · entry 7 Archbold Brian David · CIK 0001776947 · SVP Continuous Improvement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,891 Underlying: Common Stock · 420 shares Expires 2024-04-02 F2 · derivative.exercise_date: 1/5 exercisable on each anniversary date of the 4/2/18 grant date Read SEC document |
| August 10, 2020 Filed Aug 13, 2020 20:31 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 145 | $0.00 Strike: $129.10 | $0.00 |
DisclosureSEC source: 0001437749-20-017829 · rdgdoc.xml · derivative · entry 6 Archbold Brian David · CIK 0001776947 · SVP Continuous Improvement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,311 Underlying: Common Stock · 145 shares Expires 2024-01-08 F1 · derivative.exercise_date: 1/5 exercisable on each anniversary date of the 1/08/18 grant date Read SEC document |
| August 10, 2020 Filed Aug 13, 2020 20:31 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 38 | $250.00 | $9,500.00 |
DisclosureSEC source: 0001437749-20-017829 · rdgdoc.xml · nonDerivative · entry 5 Archbold Brian David · CIK 0001776947 · SVP Continuous Improvement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232 Read SEC document |
| August 10, 2020 Filed Aug 13, 2020 20:31 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 420 | $250.00 | $105,000.00 |
DisclosureSEC source: 0001437749-20-017829 · rdgdoc.xml · nonDerivative · entry 4 Archbold Brian David · CIK 0001776947 · SVP Continuous Improvement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270 Read SEC document |
| August 10, 2020 Filed Aug 13, 2020 20:31 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 420 | $142.40 | $59,808.00 |
DisclosureSEC source: 0001437749-20-017829 · rdgdoc.xml · nonDerivative · entry 3 Archbold Brian David · CIK 0001776947 · SVP Continuous Improvement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 690 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2020 Filed Aug 13, 2020 20:31 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 145 | $250.00 | $36,250.00 |
DisclosureSEC source: 0001437749-20-017829 · rdgdoc.xml · nonDerivative · entry 2 Archbold Brian David · CIK 0001776947 · SVP Continuous Improvement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270 Read SEC document |
| August 10, 2020 Filed Aug 13, 2020 20:31 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 145 | $129.10 | $18,719.50 |
DisclosureSEC source: 0001437749-20-017829 · rdgdoc.xml · nonDerivative · entry 1 Archbold Brian David · CIK 0001776947 · SVP Continuous Improvement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 415 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 16:34 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 3 · Derivative | 419 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000018 · primary_doc.xml · derivative · entry 6 Archbold Brian David · CIK 0001776947 · SVP Continuous Improvement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 419 Underlying: Common Stock · 419 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F7 · shares: RSUs granted for 10% salary reduction for 12 months and conversion of 60% of cash bonus target for Fiscal Year 21 F8 · derivative.exercise_date: RSUs that cliff vest June 15, 2021 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 16:34 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantNon Qualified Stock Options · Derivative | 2,697 | $0.00 Strike: $226.72 | $0.00 |
DisclosureSEC source: 0001228924-20-000018 · primary_doc.xml · derivative · entry 5 Archbold Brian David · CIK 0001776947 · SVP Continuous Improvement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,456 Underlying: Common Stock · 2,697 shares Expires 2026-06-15 F6 · derivative.exercise_date: NSOs that vest approximately 1/3 on June 15, 2021 and each of the next two anniversary dates Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 16:34 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 2 · Derivative | 812 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000018 · primary_doc.xml · derivative · entry 4 Archbold Brian David · CIK 0001776947 · SVP Continuous Improvement 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 812 Underlying: Common Stock · 812 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F5 · derivative.exercise_date: RSUs that vest approximately 1/3 on June 15, 2021 and each of the next two anniversary dates. F3 · derivative.expiration_date: Not Applicable Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.